New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
05:55 EDTAEGR, AEGR, CTCM, CTCM, LINC, LINC, SPLS, SPLS, BFA, BFACompanies reporting Before the Market Open on Wednesday, March 6
Notable companies reporting before the opening bell include Aegerion Pharmaceuticals (AEGR), CTC Media (CTCM), Lincoln Educational Services (LINC), Staples (SPLS) and Brown-Forman (BFA).
News For AEGR;CTCM;LINC;SPLS;BFA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
09:28 EDTAEGRAegerion board backs CEO amid drug claims, TheStreet reports
Subscribe for More Information
06:37 EDTCTCMCTC Media backs 2014 OIBDA margin view around 30%
Subscribe for More Information
06:35 EDTCTCMCTC Media reports Q3 EPS 20c vs. 30c a year ago
Reports Q3 revenue $158.57M vs. one estimate $155.00M and $171.08M a year ago.
October 27, 2014
17:23 EDTLINCParadice Investment Management reports 6% passive stake in Lincoln Educational
10:52 EDTAEGRSeattle Genetics, Aegerion CEOs accused of drug use in lawsuit, TheStreet says
Subscribe for More Information
October 22, 2014
07:35 EDTAEGRCardiometabolic Health Congress to hold annual meeting
Subscribe for More Information
October 21, 2014
06:22 EDTSPLSStaples may be latest retailer to be hacked, Krebs reports
Subscribe for More Information
October 20, 2014
10:24 EDTSPLSStaples and Cynthia Rowley announce exclusive collaboration
Staples and designer Cynthia Rowley announce an exclusive work and home office collection that incorporates designs into everyday work and home spaces. Beginning mid-November, Staples stores nationwide will debut the exclusive Cynthia Rowley Collection.
07:24 EDTAEGRAegerion price target lowered to $46 from $66 at Leerink
Leerink lowered its price target for Aegerion shares to $46 after its survey of 40 U.S. cardiologists implied a more bearish outlook for Juxtapid once PCSK9s emerge. The firm, however, believes new patient adds are well outpacing Juxtapid discontinuations in the near term. It keeps an Outperform rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use